DTNBP1 and schizophrenia: In agreement with these reports, a recent study has demonstrated that the antipsychotic risperidone may ameliorate executive functions in both schizophrenia patients and mice carrying a genetic variation of the Dysbindin gene reducing dysbindin-1 levels [156].